{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:36:16Z","timestamp":1714696576356},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,2]]},"DOI":"10.7759\/cureus.59542","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T22:25:32Z","timestamp":1714688732000},"source":"Crossref","is-referenced-by-count":0,"title":["Extensive Thrombosis in Catastrophic Antiphospholipid Syndrome in a Newly Diagnosed Systemic Lupus Erythematosus: A Case Report"],"prefix":"10.7759","author":[{"given":"Manasawee","family":"Tanariyakul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Nebrajas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakditad","family":"Saowapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natchaya","family":"Polpichai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/01.JAA.0000526771.67820.59","article-title":"Antiphospholipid antibody syndrome: the difficulties of diagnosis","volume":"30","author":"Whitaker KL","year":"2017","unstructured":"Whitaker KL. Antiphospholipid antibody syndrome: the difficulties of diagnosis. JAAPA. 2017, 30:10-4. 10.1097\/01.JAA.0000526771.67820.59","journal-title":"JAAPA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3284258","article-title":"Alveolar hemorrhage, a rare and life-threatening complication of catastrophic antiphospholipid syndrome","volume":"2019","author":"Loza G","year":"2019","unstructured":"Loza G, Hallo C, Chiliquinga B, Hallo A. Alveolar hemorrhage, a rare and life-threatening complication of catastrophic antiphospholipid syndrome. Case Rep Rheumatol. 2019, 2019:3284258. 10.1155\/2019\/3284258","journal-title":"Case Rep Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.02.008","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \"CAPS Registry\"","volume":"32","author":"Cervera R","year":"2009","unstructured":"Cervera R, Bucciarelli S, Plas\u00edn MA, et al.. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \"CAPS Registry\". J Autoimmun. 2009, 32:240-5. 10.1016\/j.jaut.2009.02.008","journal-title":"J Autoimmun"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson RA","year":"2003","unstructured":"Asherson RA, Cervera R, de Groot PG, et al.. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003, 12:530-4. 10.1191\/0961203303lu394oa","journal-title":"Lupus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya M","year":"2023","unstructured":"Barbhaiya M, Zuily S, Naden R, et al.. 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2023, 82:1258-70. 10.1136\/ard-2023-224609","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X13502919","article-title":"Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease","volume":"5","author":"Aguiar CL","year":"2013","unstructured":"Aguiar CL, Erkan D. Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease. Ther Adv Musculoskelet Dis. 2013, 5:305-14. 10.1177\/1759720X13502919","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2016.07.004","article-title":"Catastrophic antiphospholipid syndrome: the current management approach","volume":"30","author":"Rodriguez-Pint\u00f3 I","year":"2016","unstructured":"Rodriguez-Pint\u00f3 I, Espinosa G, Cervera R. Catastrophic antiphospholipid syndrome: the current management approach. Best Pract Res Clin Rheumatol. 2016, 30:239-49. 10.1016\/j.berh.2016.07.004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/341342","article-title":"An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions","volume":"2014","author":"Emmi G","year":"2014","unstructured":"Emmi G, Silvestri E, Squatrito D, et al.. An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions. ScientificWorldJournal. 2014, 2014:341342. 10.1155\/2014\/341342","journal-title":"ScientificWorldJournal"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001078","article-title":"A case of probable catastrophic antiphospholipid syndrome treated with rituximab and without anticoagulation","volume":"27","author":"Liu LW","year":"2021","unstructured":"Liu LW, Tsai HH, Lafian A, Sadeghi-Najafabadi E. A case of probable catastrophic antiphospholipid syndrome treated with rituximab and without anticoagulation. J Clin Rheumatol. 2021, 27:S541-2. 10.1097\/RHU.0000000000001078","journal-title":"J Clin Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.3.195","article-title":"The lung in the antiphospholipid syndrome","volume":"61","author":"Espinosa G","year":"2002","unstructured":"Espinosa G, Cervera R, Font J, Asherson RA. The lung in the antiphospholipid syndrome. Ann Rheum Dis. 2002, 61:195-8. 10.1136\/ard.61.3.195","journal-title":"Ann Rheum Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10268","article-title":"Catastrophic antiphospholipid antibody syndrome","volume":"72","author":"Moll S","year":"2003","unstructured":"Moll S, Kudrik FJ, Thomas DB. Catastrophic antiphospholipid antibody syndrome. Am J Hematol. 2003, 72:278-9. 10.1002\/ajh.10268","journal-title":"Am J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199805000-00005","article-title":"Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients","volume":"77","author":"Asherson RA","year":"1998","unstructured":"Asherson RA, Cervera R, Piette JC, et al.. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore). 1998, 77:195-207. 10.1097\/00005792-199805000-00005","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/0961203310395052","article-title":"Task Force on catastrophic antiphospholipid syndrome (APS) and non-criteria APS manifestations (ii): thrombocytopenia and skin manifestations","volume":"20","author":"Cervera R","year":"2011","unstructured":"Cervera R, Tektonidou MG, Espinosa G, et al.. Task Force on catastrophic antiphospholipid syndrome (APS) and non-criteria APS manifestations (ii): thrombocytopenia and skin manifestations. Lupus. 2011, 20:174-81. 10.1177\/0961203310395052","journal-title":"Lupus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/art.22018","article-title":"Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients","volume":"54","author":"Bucciarelli S","year":"2006","unstructured":"Bucciarelli S, Espinosa G, Cervera R, et al.. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum. 2006, 54:2568-76. 10.1002\/art.22018","journal-title":"Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.4.421","article-title":"Intravenous immunoglobulin therapy of antiphospholipid syndrome","volume":"39","author":"Sherer Y","year":"2000","unstructured":"Sherer Y, Levy Y, Shoenfeld Y. Intravenous immunoglobulin therapy of antiphospholipid syndrome. Rheumatology (Oxford). 2000, 39:421-6. 10.1093\/rheumatology\/39.4.421","journal-title":"Rheumatology (Oxford)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/242927-extensive-thrombosis-in-catastrophic-antiphospholipid-syndrome-in-a-newly-diagnosed-systemic-lupus-erythematosus-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T22:25:36Z","timestamp":1714688736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/242927-extensive-thrombosis-in-catastrophic-antiphospholipid-syndrome-in-a-newly-diagnosed-systemic-lupus-erythematosus-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.59542","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,2]]}}}